{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:01Z","timestamp":1790542621290,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03 DA059659"],"award-info":[{"award-number":["R03 DA059659"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpmfocus.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJPM Focus"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.focus.2026.100536","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:05:40Z","timestamp":1784736340000},"page":"100536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring Sexually Transmitted and Bloodborne Infection Rates in Florida After Implementation of Syringe Services Programs: A Quasi-Experimental Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0840-0226","authenticated-orcid":false,"given":"Bedis","family":"Elkamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6058-5053","authenticated-orcid":false,"given":"Shelby M.","family":"Meaders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2053-0880","authenticated-orcid":false,"given":"Teresa A.","family":"Chueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5504-149X","authenticated-orcid":false,"given":"Joy D.","family":"Scheidell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.focus.2026.100536_bib0001","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10461-012-0276-0","article-title":"Non-injection and injection drug use and STI\/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users","volume":"17","author":"Khan","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.focus.2026.100536_bib0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.annepidem.2020.03.011","article-title":"Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992\u20132013","volume":"45","author":"Williams","year":"2020","journal-title":"Ann Epidemiol"},{"issue":"7","key":"10.1016\/j.focus.2026.100536_bib0003","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/v16071115","article-title":"Prevalence and modes of transmission of hepatitis C virus infection: a historical worldwide review","volume":"16","author":"Stroffolini","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.focus.2026.100536_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: a national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"issue":"8","key":"10.1016\/j.focus.2026.100536_bib0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/OLQ.0000000000000633","article-title":"Narrative review: sexually transmitted diseases and homeless youth-what do we know about sexually transmitted disease prevalence and risk?","volume":"44","author":"Caccamo","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.focus.2026.100536_bib0006","doi-asserted-by":"crossref","first-page":"144","DOI":"10.15585\/mmwr.mm6806a4","article-title":"Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis - United States, 2013\u20132017","volume":"68","author":"Kidd","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.focus.2026.100536_bib0007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe Programmes in people who inject drugs - an overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.focus.2026.100536_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109323","article-title":"Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020","volume":"232","author":"Behrends","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12954-024-01116-5","article-title":"Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities","volume":"21","author":"Scheidell","year":"2024","journal-title":"Harm Reduct J"},{"issue":"4","key":"10.1016\/j.focus.2026.100536_bib0011","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2105\/AJPH.2019.305515","article-title":"Expansion of syringe service programs in the United States, 2015\u20132018","volume":"110","author":"Des Jarlais","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.focus.2026.100536_bib0012","unstructured":"Harm reduction locations. North American Syringe Exchange Network (NASEN). https:\/\/nasen.org\/. Updated August 21, 2026. Accessed April 4, 2025."},{"issue":"1\u20133","key":"10.1016\/j.focus.2026.100536_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.drugalcdep.2011.12.001","article-title":"A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs","volume":"123","author":"Tookes","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.focus.2026.100536_bib0014","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/ACM.0000000000003557","article-title":"The University of Miami infectious disease elimination act syringe services program: a blueprint for student advocacy, education, and innovation","volume":"96","author":"Tookes","year":"2021","journal-title":"Acad Med"},{"issue":"7","key":"10.1016\/j.focus.2026.100536_bib0015","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2105\/AJPH.2020.305705","article-title":"Student-run free clinic at a syringe services program, Miami, Florida, 2017\u20132019","volume":"110","author":"Ginoza","year":"2020","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12954-021-00563-8","article-title":"Implementation and first-year operating costs of an academic medical center-based syringe services program","volume":"18","author":"Bartholomew","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.focus.2026.100536_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmqr.2024.100421","article-title":"Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes","volume":"5","author":"Akiba","year":"2024","journal-title":"SSM Qual Res Health"},{"issue":"suppl 2","key":"10.1016\/j.focus.2026.100536_bib0018","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/QAI.0000000000002176","article-title":"Using interrupted time series analysis to measure the impact of legalized syringe exchange on HIV diagnoses in Baltimore and Philadelphia","volume":"82","author":"Ruiz","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.focus.2026.100536_bib0019","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/cid\/ciz321","article-title":"Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study","volume":"70","author":"Goedel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.focus.2026.100536_bib0020","unstructured":"Reportable and infectious diseases. Florida Department of Health.https:\/\/www.flhealthcharts.gov\/charts\/CommunicableDiseases\/default.aspx. Updated September 4, 2023. Accessed April 4, 2025."},{"key":"10.1016\/j.focus.2026.100536_bib0021","unstructured":"HIV.gov. EHE priority jurisdictions. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/jurisdictions. Updated September 8, 2026. Accessed September 18, 2026."},{"issue":"4","key":"10.1016\/j.focus.2026.100536_bib0022","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40471-020-00245-2","article-title":"Difference-in-difference in the time of cholera: a gentle introduction for epidemiologists","volume":"7","author":"Caniglia","year":"2020","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.focus.2026.100536_bib0023","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-publhealth-040617-013507","article-title":"Designing difference in difference studies: best practices for public health policy research","volume":"39","author":"Wing","year":"2018","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.focus.2026.100536_bib0024","series-title":"Paper presented at: German Stata Users' Group Meetings","article-title":"Difference-in-difference estimation using Stata","author":"Luedicke","year":"2022"},{"issue":"2","key":"10.1016\/j.focus.2026.100536_bib0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1162\/rest_a_00887","article-title":"The wild bootstrap with a \u201csmall\u201d number of \u201clarge\u201d clusters","volume":"103","author":"Canay","year":"2021","journal-title":"Rev Econ Stat"},{"issue":"7","key":"10.1016\/j.focus.2026.100536_bib0026","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jval.2022.06.017","article-title":"Revising the suspected-cancer guidelines: impacts on patients\u2019 primary care contacts and costs","volume":"26","author":"Price","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.focus.2026.100536_bib0027","series-title":"Sexually transmitted infections surveillance, 2023","year":"2024"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0028","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"suppl 1","key":"10.1016\/j.focus.2026.100536_bib0029","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/0033354920936233","article-title":"Making the case for syringe services programs","volume":"135","author":"Adams","year":"2020","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.focus.2026.100536_bib0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/QAI.0b013e3181a2539a","article-title":"The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis","volume":"51","author":"Kwon","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.focus.2026.100536_bib0031","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/QAD.0000000000003199","article-title":"The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study","volume":"36","author":"Zang","year":"2022","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0032","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12954-020-00395-y","article-title":"Providing reproductive health services for women who inject drugs: a pilot program","volume":"17","author":"Owens","year":"2020","journal-title":"Harm Reduct J"},{"issue":"11","key":"10.1016\/j.focus.2026.100536_bib0033","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/OLQ.0000000000000516","article-title":"Reducing missed opportunities: pairing sexually transmitted infection screening with syringe exchange services","volume":"43","author":"Roth","year":"2016","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.focus.2026.100536_bib0034","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-017-0156-z","article-title":"Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis","volume":"14","author":"Davis","year":"2017","journal-title":"Harm Reduct J"},{"issue":"4","key":"10.1016\/j.focus.2026.100536_bib0036","doi-asserted-by":"crossref","first-page":"ofaa092","DOI":"10.1093\/ofid\/ofaa092","article-title":"Per-contact infectivity of hepatitis C virus acquisition in association with receptive needle sharing exposures in a prospective cohort of young adult people who inject drugs in San Francisco, California","volume":"7","author":"Leyva","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0037","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12954-021-00505-4","article-title":"Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis","volume":"18","author":"Shayan","year":"2021","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.focus.2026.100536_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108344","article-title":"Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida","volume":"127","author":"Bartholomew","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"10.1016\/j.focus.2026.100536_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104515","article-title":"Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions","volume":"9","author":"Palmateer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.focus.2026.100536_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104289","article-title":"Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019\u20132020","volume":"123","author":"Tookes","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.focus.2026.100536_bib0041","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12954-020-00385-0","article-title":"Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL","volume":"17","author":"Bartholomew","year":"2020","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.focus.2026.100536_bib0042","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jvh.13664","article-title":"The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: an Australian pilot study","volume":"29","author":"Howell","year":"2022","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.focus.2026.100536_bib0043","doi-asserted-by":"crossref","first-page":"ofaf211","DOI":"10.1093\/ofid\/ofaf211","article-title":"Approaches to offering hepatitis C treatment at syringe services programs in the United States: a scoping review","volume":"12","author":"Yoder","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.focus.2026.100536_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104107","article-title":"\u2018New evidence\u2019 for Syringe Services Programs? A call for rigor and skepticism","volume":"121","author":"Lambdin","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.focus.2026.100536_bib0045","unstructured":"Impact of COVID-19 on STIs. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/sti-statistics\/about\/impact-of-covid-19.html. Updated November 12, 2024. Accessed June, 2025."}],"container-title":["AJPM Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065426000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065426000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:07:41Z","timestamp":1790539661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773065426000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2773065426000623"],"URL":"https:\/\/doi.org\/10.1016\/j.focus.2026.100536","relation":{},"ISSN":["2773-0654"],"issn-type":[{"value":"2773-0654","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring Sexually Transmitted and Bloodborne Infection Rates in Florida After Implementation of Syringe Services Programs: A Quasi-Experimental Study","name":"articletitle","label":"Article Title"},{"value":"AJPM Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.focus.2026.100536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100536"}}